» Articles » PMID: 10997287

Peroxisome Proliferator Activated Receptor Agonists

Overview
Journal EXS
Date 2000 Sep 21
PMID 10997287
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

The peroxisome proliferator activated receptors (PPARs) represent a group of ligand-activated transcription factors that mediate the biological effects of various drugs, such as fibrates and thiazolidinediones. Three PPAR subtypes can be distinguished, alpha, beta and gamma, each of which has an unique pattern of expression among vertebrate tissues. The PPAR alpha receptor is activated by hypolipidemic drugs of the fibrate class, and regulates the expression of numerous genes involved in fatty acid catabolism. The PPAR gamma receptor is activated by hypoglycaemic drugs of the thiazolidinedione class, and is an important determinant of adipocyte differentiation. Little is currently known about PPAR beta. A heavy research effort is currently directed towards the identification of novel high-affinity, high-specificity agonists and antagonists that may be used in the treatment of hyperglycaemia, hyperlipidemia, and other diseases of metabolic origin.

Citing Articles

PPARs in Clinical Experimental Medicine after 35 Years of Worldwide Scientific Investigations and Medical Experiments.

Skoczynska A, Oldakowska M, Dobosz A, Adamiec R, Gritskevich S, Jonkisz A Biomolecules. 2024; 14(7).

PMID: 39062500 PMC: 11275227. DOI: 10.3390/biom14070786.


Circulating Metabolites as Biomarkers of Disease in Patients with Mesial Temporal Lobe Epilepsy.

Godoi A, do Canto A, Donatti A, Rosa D, Bruno D, Alvim M Metabolites. 2022; 12(5).

PMID: 35629950 PMC: 9148034. DOI: 10.3390/metabo12050446.


Branched-Chain Fatty Acids as Mediators of the Activation of Hepatic Peroxisome Proliferator-Activated Receptor Alpha by a Fungal Lipid Extract.

Maheshwari G, Ringseis R, Wen G, Gessner D, Rost J, Fraatz M Biomolecules. 2020; 10(9).

PMID: 32878262 PMC: 7565516. DOI: 10.3390/biom10091259.


PPARα Between Aspirin and Plaque Clearance.

Chandra S, Roy A, Patel D, Pahan K J Alzheimers Dis. 2019; 71(2):389-397.

PMID: 31424405 PMC: 8163018. DOI: 10.3233/JAD-190586.


Gemfibrozil, a Lipid-Lowering Drug, Lowers Amyloid Plaque Pathology and Enhances Memory in a Mouse Model of Alzheimer's Disease via Peroxisome Proliferator-Activated Receptor .

Chandra S, Pahan K J Alzheimers Dis Rep. 2019; 3(1):149-168.

PMID: 31259309 PMC: 6597963. DOI: 10.3233/ADR-190104.